Dr Cynthia Louise Miller, MD | |
3816 Woodruff Ave, Ste # 307, Long Beach, CA 90808 | |
(562) 420-7670 | |
(562) 429-4064 |
Full Name | Dr Cynthia Louise Miller |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 42 Years |
Location | 3816 Woodruff Ave, Long Beach, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437245669 | NPI | - | NPPES |
00G517920 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | G51792 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Long Beach Memorial Medical Center | Long beach, CA | Hospital |
Intercommunity Healthcare & Rehabilitation Center | Norwalk, CA | Nursing home |
Country Villa Belmont Heights | Long beach, CA | Nursing home |
Rosecrans Care Center | Gardena, CA | Nursing home |
Lakewood Healthcare Center | Downey, CA | Nursing home |
Briarcrest Nursing Center | Bell gardens, CA | Nursing home |
Entity Name | Cynthia L Miller Dobalian A Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699040535 PECOS PAC ID: 0446419584 Enrollment ID: O20120309000387 |
News Archive
A new study suggests that a woman's ability to read emotions may be negatively impacted by the contraceptive pill.
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Dr. Reddy's Laboratories announced today that it has launched Quetiapine fumarate tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg), a bioequivalent generic version of SEROQUEL tablets in the US market on March 27, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Quetiapine fumarate tablets.
Scientists from Scientific and Educational Center & Smart Materials and Biomedical Applications under the leadership of Kateryna Levada together with colleagues from Center for Immunology and Cellular Biotechnology of the Immanuel Kant Baltic Federal University conducted a joint interdisciplinary study on the development of a new method for treating leukemia using nanomaterials.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Cynthia Louise Miller, MD 3816 Woodruff Ave, Ste # 307, Long Beach, CA 90808 Ph: (562) 420-7670 | Dr Cynthia Louise Miller, MD 3816 Woodruff Ave, Ste # 307, Long Beach, CA 90808 Ph: (562) 420-7670 |
News Archive
A new study suggests that a woman's ability to read emotions may be negatively impacted by the contraceptive pill.
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Dr. Reddy's Laboratories announced today that it has launched Quetiapine fumarate tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg), a bioequivalent generic version of SEROQUEL tablets in the US market on March 27, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Quetiapine fumarate tablets.
Scientists from Scientific and Educational Center & Smart Materials and Biomedical Applications under the leadership of Kateryna Levada together with colleagues from Center for Immunology and Cellular Biotechnology of the Immanuel Kant Baltic Federal University conducted a joint interdisciplinary study on the development of a new method for treating leukemia using nanomaterials.
› Verified 7 days ago
Sohrab Tanavoli, D.O Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5901 E 7th St, Long Beach, CA 90822 Phone: 562-826-8000 | |
Ngoc-tram Gia Tran, D.O Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2888 Long Beach Blvd Ste 235, Long Beach, CA 90806 Phone: 562-803-2486 | |
Michael A Raya, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Redondo Ave, Long Beach, CA 90806 Phone: 562-988-7000 | |
Meggan Chappell, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3833 Worsham Ave Ste 300, Long Beach, CA 90808 Phone: 562-595-5421 Fax: 562-426-2862 | |
Dr. Maurice A Bell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 Long Beach Blvd, Suite 200, Long Beach, CA 90807 Phone: 562-981-2355 Fax: 562-981-2920 | |
Katya C Corado, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1333 Chestnut Ave, Long Beach, CA 90813 Phone: 562-599-8601 Fax: 562-218-0853 | |
Dr. Diane L. Johnson, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 65 Pine Ave, #19, Long Beach, CA 90802 Phone: 714-402-4685 Fax: 562-856-0389 |